News
Novartis’ Afinitor, for treatment in combination with Aromasin, for patients with certain advanced breast cancers, has been approved by the US FDA. The US FDA has approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain…
J&J’s second-quarter financial results initiate debate amongst analysts as to what the future of the US healthcare giant holds. Johnson & Johnson has announced its second-quarter 2012 financial results – and it does not look…
Late-stage clinical trial of Alzheimer’s drug fails to slow disease. A drug developed by Pfizer, Johnson & Johnson and Elan Corp. to treat Alzheimer’s failed to slow the disease in a late-stage trial…
Sanofi and Regeneron announce the launch of their phase 3 clinical program, ODYSSEY, for the evaluation of SAR236553/REGN727, a potential PCSK9 inhibitor. Sanofi and Regeneron Pharmaceuticals, Inc. have announced that several clinical trials have initiated patient enrolment…
Polypill demonstrates encouraging results in reducing risk factors for heart attack and stroke. An all-in-one treatment that could potentially save tens of thousands of lives could be available in the UK within the next two…
Novartis’ second quarter results show the healthcare company’s significant regulatory milestones and prove it is on track to deliver 2012 outlook. By the looks of Novartis’ second quarter profit results it is clear the healthcare company is well-positioned to continue delivering…
The FDA approves its second weight-loss drug in a few weeks to help tackle the growing obesity epidemic in America. The FDA has announced it has approved a new weight-loss drug, called Qsymia, expanding the range…
US-based generic-drug maker, Par Pharmaceutical, has agreed to be acquired by TPG Capital. Private equity-firm, TPG Capital, has entered into a definitive agreement to acquire US-based Par Pharmaceutical…
UK’s NICE has launched a new advisory service entitled Evidence summaries: new medicines to provide information and support for the NHS and patients in England. The National Institute for Health and Clinical Excellence (NICE) has launched a new service to provide high quality information to…
